Neuroleptic malignant syndrome.
Larner
A J
AJ
D015415:Biomarkers; D003620:Dantrolene / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D008297:Male; D008305:Malignant Hyperthermia / Q000188:drug therapy* / Q000503:physiopathology; D009127:Muscle Rigidity / Q000209:etiology / Q000473:pathology / Q000503:physiopathology; D015213:Neuroimmunomodulation; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D012433:Ryanodine / Q000276:immunology / Q000494:pharmacology / Q000627:therapeutic use
D015415:Biomarkers; D012433:Ryanodine; D003620:Dantrolene